Moxisylyte hydrochloride
Moxisylyte hydrochloride structure
|
Common Name | Moxisylyte hydrochloride | ||
|---|---|---|---|---|
| CAS Number | 964-52-3 | Molecular Weight | 315.83600 | |
| Density | 1.018g/cm3 | Boiling Point | 371ºC at 760mmHg | |
| Molecular Formula | C16H26ClNO3 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | 178.2ºC | |
| Symbol |
GHS07 |
Signal Word | Warning | |
|
Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte.
J. Auton. Nerv. Syst. 79 , 191-195, (2000) Lower urinary tract dysfunction is a major cause of morbidity in patients with multiple system atrophy (MSA). alpha1-Adrenergic receptors are present in the proximal urethra where impaired relaxation may be responsible for voiding difficulty and a large amoun... |
|
|
Moxisylyte: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in impotence.
Fundam. Clin. Pharmacol. 12 , 377-387, (1998) Moxisylyte is a competitive noradrenaline antagonist, acting preferentially on post-synaptic alpha-1 adrenoceptors. It was introduced more than thirty years ago for the treatment of cerebro-vascular disorders and shown more recently effective in the urologica... |
Journals:
More...